NZ238631A - Preparation of antibacterial beta-lactam derivatives: compounds produced thereby - Google Patents

Preparation of antibacterial beta-lactam derivatives: compounds produced thereby

Info

Publication number
NZ238631A
NZ238631A NZ238631A NZ23863191A NZ238631A NZ 238631 A NZ238631 A NZ 238631A NZ 238631 A NZ238631 A NZ 238631A NZ 23863191 A NZ23863191 A NZ 23863191A NZ 238631 A NZ238631 A NZ 238631A
Authority
NZ
New Zealand
Prior art keywords
hydrogen
acid
formula
compound
methyl
Prior art date
Application number
NZ238631A
Other languages
English (en)
Inventor
Theodor Denzel
Christopher M Cimarusti
Janak Singh
Richard H Mueller
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NZ238631A publication Critical patent/NZ238631A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ238631A 1990-06-29 1991-06-20 Preparation of antibacterial beta-lactam derivatives: compounds produced thereby NZ238631A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/546,622 US5194604A (en) 1990-06-29 1990-06-29 Process and intermediates for beta-lactams having aminothiazole(iminooxyacetic acid)acetic acid sidechains

Publications (1)

Publication Number Publication Date
NZ238631A true NZ238631A (en) 1993-10-26

Family

ID=24181260

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ238631A NZ238631A (en) 1990-06-29 1991-06-20 Preparation of antibacterial beta-lactam derivatives: compounds produced thereby

Country Status (20)

Country Link
US (1) US5194604A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0464705A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH04261175A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR920000757A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1029965C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU645810B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2043817A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI913138L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU211083B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE912174A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL98395A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX26368A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY107234A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO912560L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ238631A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL165404B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT98139A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2021270C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW201310B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA914348B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045290A1 (fr) * 1997-04-04 1998-10-15 Tokuyama Corporation Derives de 2-aminothiazoleacetamide
US7214364B2 (en) 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
DE122011100043I1 (de) 2000-12-27 2011-12-15 Gilead Sciences Inc Inhalierbares aztreonam zur behandlung und vorbeugung von bakteriellen lungeninfektionen.
CN1681812A (zh) 2002-08-05 2005-10-12 特瓦药厂有限公司 氨曲南的制备
CN1802371A (zh) * 2003-05-15 2006-07-12 特瓦药厂有限公司 残余溶剂含量极低的阿兹托南β多晶型
AU2004256124B2 (en) * 2003-07-02 2011-04-28 Corus Pharma, Inc. Aztreonam L-lysine and methods for the preparation thereof
ES2321336T3 (es) * 2005-05-09 2009-06-04 Sicor Inc. Procedimiento para la fabricacion de aztreonam.
WO2015051101A1 (en) 2013-10-02 2015-04-09 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
CN103554054B (zh) * 2013-11-20 2015-03-25 山东金城医药化工股份有限公司 他啶侧链双酸的制备方法
CN104447610A (zh) * 2014-11-21 2015-03-25 山东金城医药化工股份有限公司 高纯度头孢他啶侧链酸的制备方法
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1299223A (en) * 1969-03-25 1972-12-13 Sankyo Co 6-aminopenicillanic acid compounds and novel cycloheptimidazolone compounds
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4533660A (en) * 1980-10-31 1985-08-06 E. R. Squibb & Sons, Inc. Antibacterial O-sulfated β-lactam hydroxamic acids
US4782147A (en) * 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4386034A (en) * 1981-02-02 1983-05-31 E. R. Squibb & Sons, Inc. Sulfamated amino acid amides
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
ATE30724T1 (de) * 1982-06-28 1987-11-15 Bristol Myers Co Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten.
US4500526A (en) * 1982-06-28 1985-02-19 Bristol-Myers Company Cephalosporin derivatives
JPS60112789A (ja) * 1983-11-21 1985-06-19 Otsuka Chem Co Ltd ３−アシルアミノ−４−アルキル−２−アゼチジノン−１−スルホン酸誘導体、その製造方法および該誘導体を含有する薬剤
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics

Also Published As

Publication number Publication date
FI913138A7 (fi) 1991-12-30
MX26368A (es) 1994-02-28
HUT58090A (en) 1992-01-28
KR920000757A (ko) 1992-01-29
FI913138A0 (fi) 1991-06-27
FI913138L (fi) 1991-12-30
NO912560D0 (no) 1991-06-28
JPH04261175A (ja) 1992-09-17
CN1058593A (zh) 1992-02-12
IL98395A0 (en) 1992-07-15
PL290856A1 (en) 1992-09-21
HU211083B (en) 1995-10-30
PT98139A (pt) 1993-09-30
AU645810B2 (en) 1994-01-27
AU7816391A (en) 1992-01-02
MY107234A (en) 1995-10-31
EP0464705A1 (en) 1992-01-08
CA2043817A1 (en) 1991-12-30
ZA914348B (en) 1992-03-25
IE912174A1 (en) 1992-01-01
US5194604A (en) 1993-03-16
HU912202D0 (en) 1991-12-30
RU2021270C1 (ru) 1994-10-15
PL165404B1 (pl) 1994-12-30
CN1029965C (zh) 1995-10-11
TW201310B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-03-01
NO912560L (no) 1991-12-30

Similar Documents

Publication Publication Date Title
RU2107067C1 (ru) Производные 1-карба-(1-детиа)-цефема
US5210266A (en) N-substituted mercaptopropanamide derivatives
FR2503712A1 (fr) Composes de la cephalosporine et procede pour leur preparation
EP0177940B1 (en) Hydrazine derivatives and their use
US7405294B2 (en) Intermediate cefdinir salts
NZ238631A (en) Preparation of antibacterial beta-lactam derivatives: compounds produced thereby
GB2125794A (en) Azetidine compounds
GB2111482A (en) Azetidine medicaments
JPH11255772A (ja) ホスフォノセフェム誘導体、その製造法および用途
EP0266896B1 (en) 7-( (meta-substituted) phenylglycine) 1-carba-1-dethiacephalosporins
US20050227914A1 (en) New process
KR100223384B1 (ko) 삼중수화된 세픽시미(cefixime)의 제조방법
FI91865C (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-okso-1-//(substituoitu sulfonyyli)amino/karbonyyli/atsetidiinien valmistamiseksi
KR900005112B1 (ko) 2-옥소-1-아제티딘술폰산 유도체의 제조방법
GB2141428A (en) 3-acylamino-2-bcta-dioxo-azetidine-propanoic acid derivitives
IE54430B1 (en) Process for preparing (3s)-3-((2-amino-4-thiazolyl) ((1-carboxy-1-methylethoxy) -acetyl) amino) -2-oxo-1-azetidine-sulfonic acid, and 4-substituted derivatives
AU614558B2 (en) N-substituted mercaptopropanamide derivatives
CN1305484A (zh) 3－(2－氧－[1,3′]二吡咯烷基－3－基亚基甲基)－头孢
JP3514495B2 (ja) ハロゲン化アミノチアジアゾリル酢酸誘導体の製造法
NZ205642A (en) Beta-lactams and pharmaceutical compositions
EP0200159A2 (en) 3-Acylamino-2-oxo-1-azetidinesulfonic acids
Koh et al. New Aminothiazolyl Cephalosporins. Synthesis and Biological Evaluation of 7-[Alkoxyiminomethyl (2-aminothiazol-4-yl) acetamido] ceph-3-em-4-carboxylic Acids
NZ199828A (en) 4-substituted mercapto-2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutical compositions
AU711047B2 (en) Metalloproteinase inhibitors
JPH06340662A (ja) カテコールスルホン酸基含有モノバクタムヒドラジド化合物